The pharmacologic action and clinical investigation of new anti-atrial fibrillation drugs, such as dofetilide, sotalol, ibutilide are reviewed in this paper.
The assessment comes as a U. S. Food and Drug Administration advisory panel mulls whether to recommend approval of the intravenous drug for atrial fibrillation (AF).
MedWire News: Statin treatment may help to prevent atrial fibrillation (AF) recurrence, suggests an observational study of patients implanted with a pacemaker.